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Infections with Chlamydia trachomatis (CT) can lead 
to severe sequelae; however, they are not notifiable in 
Germany. We tested urine samples from participants 
of KiGGS (German Health Interview and Examination 
Survey for Children and Adolescents) for CT infections 
and linked the results to demographic and behav-
ioural data from 1,925 participants (girls aged 15–17 
years and boys aged 16–17 years) to determine a rep-
resentative prevalence of CT infection in adolescents 
in Germany and to assess associated risk factors. 
Prevalence of CT infection was 2.2% (95% CI: 1.4–3.5) 
in girls and 0.2% (95% CI: 0.1–0.7) in boys. CT infec-
tion in girls was associated with higher use of alco-
hol, marijuana and cigarettes, lower social status, 
oral contraceptive use, pregnancy, repeated lower 
abdominal pain and higher rates of doctors’ consulta-
tions within the preceding three months and consul-
tation of gynaecologists within the last 12 months. In 
multiple logistic regression, we identified two predic-
tors for CT infection: marijuana consumption often or 
several times within the last 12 months (F(1,164)=7.56; 
p<0.05) and general health status less than ‘very 
good’ (F(1,164)=3.83; p=0.052). Given our findings, 
we recommend enhancing sex education before sexual 
debut and promoting safe sex practices regardless of 
the contraceptive method used. Well-informed con-
sumption of alcohol should be promoted, the risky 
behaviour of people intoxicated through consumption 
of marijuana highlighted and doctors’ awareness of CT 
screening enhanced.
Introduction
Infections with Chlamydia trachomatis (CT) are the 
most frequently reported urogenital, bacterial sexually 
transmitted infections (STIs) worldwide. Latest figures 
(2005) from the World Health Organization (WHO) show 
that there were an estimated 101.5 million new cases 
per year of CT infection among adults aged 15 to 49 
years [1]. 
In Europe, prevalence of CT infection among unscreened 
asymptomatic women ranges between 1.7% and 17% 
[2], with sexually active women and men under the 
age of 20 years and 25 years respectively being most 
affected. CT infections are asymptomatic in up to 90% 
of women and more than 50% of men [3]. Chlamydial 
infections can cause infertility in men and women and 
according to WHO, 10–15% of women with untreated 
infections develop symptomatic pelvic inflammatory 
disease  or other severe sequelae such as infertility 
or extrauterine pregnancies [4]. However, the effect of 
screening programmes and intensified testing, CT per-
sistence and natural history of CT infections are still 
under debate [5-10].
In Germany, infections with CT are not mandatorily 
reportable and no prevalence data exist at the national 
level. A laboratory reporting system exists only in one 
federal state, Saxony, where an increase in the number 
of reported infections has been observed, from 26.3 
per 100,000 inhabitants in 2003 to 100.8 per 100,000 
in 2009 [11]. 
Population-based studies have been performed in 
the United Kingdom (UK) (National Survey of Sexual 
Attitudes and Lifestyles, Natsal) [12], France (NatChla 
study) [13] and the United States (National Health 
and Nutrition Examination Survey, NHANES) [14] and 
prevalence of CT infection estimated. In the French 
study, which was performed among 18–29 year-olds, 
the prevalence in men was 2.5% (95% CI: 1.2–5.0) 
and 3.2% (95% CI: 2.0–5.3) in women. Infections were 
associated with last sex with a casual partner in both 
men and women, last sex with a new partner and living 
in Paris in men, and multiple partners in the last year, 
same-sex partners and low educational level in women 
[13]. In the UK study, sexual behaviour was assessed in 
16–44 year-olds, such as age at first sex, contraception 
used at first intercourse, condom usage, pregnancy 
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and history of STIs. The highest prevalence of CT infec-
tion (3.0%; 95% CI: 1.7–5.0) was found in women aged 
18–24 years. Factors associated with higher preva-
lence in both sexes were occurrence of first intercourse 
before the age of 16 years, main source of informa-
tion about sexual matters being friends and not being 
sexually competent at first intercourse [12,15]. In the 
United States study, CT prevalence of 3.9% (95% CI: 
2.2–6.9) was found in 14–19 year-old females and was 
– together with gonorrhoea, Trichomonas or herpes 
simplex virus 2 infection – associated with more life-
time sexual partners. The risk of infection was higher 
soon after sexual initiation [14].  
Within KiGGS (German Health Interview and 
Examination Survey for Children and Adolescents), the 
general health of children and adolescents aged 0–17 
years was mapped nationwide between May 2003 and 
May 2006. It was a population-based survey that col-
lected health status data from 17,641 participants in 
167 representative sites. The participation rate was 
66.6% overall. Through a brief non-responder ques-
tionnaire, it was shown that the data collected were 
representative for the health status of adolescents in 
Germany [16]. Detailed sampling methods have been 
described previously by Kamtsiuris et al. [17]. 
In our study presented here, we retrospectively tested 
urine samples from 1,925 KiGGS participants (girls 
aged 15–17 years and boys aged 16–17 years) for CT 
infection and linked the results to the participants’ 
demographic and behavioural data to determine a rep-
resentative prevalence of CT infection in adolescents 
in Germany and to assess associated risk factors. To 
our knowledge, this is the first time that representative 
population-based CT-data have been linked to demo-
graphic and behavioural data in Germany. We have 
previously reported the results of a random sample of 
12–17 year-old KiGGS participants that was tested for 
CT in pools of four [18]. However, no representative-
ness was assured due to this subsampling and we re-
tested all urine specimens in pools of four as well as in 
single testing [19]. 
In our study, we estimated the prevalence of CT infec-
tion stratified by age and sex in Germany and iden-
tified risk factors (demographic, behavioural and 
health-related) associated with CT infection, represent-
ative for German adolescents. In addition, we assessed 
the usage of healthcare structures associated with CT 
infection.
Methods
Data collection in KiGGS included questionnaires filled 
in by parents and adolescents in parallel, an interview 
and a physical examination performed by a medical 
doctor. Biological specimens were taken and results 
could be linked to survey data. Urine samples were 
stored at −50°C and retrospectively tested for CT. To 
reduce costs and given our experience with the results 
from the previous random sample [18], we limited the 
age groups to be tested to 16–17 year-old boys and 
15–17 year-old girls. 
We used BD ProbeTec ET System (strand displacement 
amplification (SDA) system), a nucleic acid amplifica-
tion test (NAAT), for pooled and single-specimen test-
ing [19]. Testing was performed between January 2009 
and February 2010. For the analyses shown here, we 
only used results from single-specimen testing. 
We divided Germany into two geographical regions 
by federal state: ‘East’ (Brandenburg, Mecklenburg-
Vorpommern, Saxony, Saxony-Anhalt, Thuringia and 
Berlin) and ‘West’ (Schleswig-Holstein, Hamburg, 
Bremen, Lower Saxony, North Rhine-Westphalia, 
Hesse, Bavaria, Rhineland-Palatinate, Saarland and 
Baden-Württemberg). 
The size of a residential municipality was defined as 
‘rural’ if it had fewer than 5,000 inhabitants, ‘provin-
cial’ if between 5,000 and <20,000, ‘urban’ if between 
20,000 and <100,000 and ‘metropolitan’ if 100,000 or 
more. 
For comparison of behavioural factors, self-reported 
variables covering the last 12 months were grouped, 
such as the consumption of alcohol (beer, wine and 
hard liquor (schnapps)) into ‘two glasses per week 
or more’ and ‘one glass per week or less’. Marijuana 
consumption was grouped as ‘often or several times’ 
(defined as ‘frequent’) and ‘once or never’. Tobacco 
smokers were defined as currently being smokers; 
non-smokers were defined as participants who did 
not report smoking at the time of the survey. Frequent 
smokers were defined as participants who reported 
smoking daily, several times or at least once a week. 
Being frequently in smoky rooms was defined as being 
in the room daily, several times a week or at least 
once a week (the duration of stay in the room was not 
defined); the analysis was stratified by smoker status 
(smoker and non-smoker).
Variables such as socio-economic and migrant status 
were defined according to standardised procedures 
within KiGGS. A value for social status was calculated 
according to Winkler [20,21] using data on the educa-
tion, occupation and net household income of par-
ents. The social status index could vary between 3 and 
21: values of 3–8 were defined as low social status, 
9–14 as medium and 15–21 as high. As the methods 
used to calculate this index were based on data from 
the national adult health survey from 1998, they were 
adjusted for inflation and changes in educational sys-
tems using data from a telephone survey performed in 
2003–04 [20]. 
The KiGGS participants were selected in a complex 
two-step sampling technique, based on a systematic 
sample of 167 study locations and local population reg-
istries. For all statistical analysis, we used sampling 
weights to adjust for sampling and study design-driven 
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unequal probabilities of the participants being selected 
for the study [16]. As the selected persons were repre-
sentative for the general population, apart from Table 
1, we report (weighted) proportions, not actual num-
bers. .
Statistical analysis was performed using the Complex 
Samples Module in SPSS Statistics Version 17.0.3 and 
18.0.0 (IBM SPSS, Chicago, IL, United States). For 
descriptive analyses of categorical data, frequencies 
and proportions were calculated. For measures of asso-
ciation chi-square and Fisher ś exact test were applied 
and odds ratios (ORs) with 95% confidence intervals 
(CIs) calculated. For continuous data, means were 
computed using the Complex Samples General Linear 
Model for linear regression analysis and Student’s two-
sample t-test. Statistical significance for all tests was 
set at the <0.05 level.
We performed multiple logistic regressions to assess 
risk factors for positive CT test results in girls aged 
15–17 years. The criterion for inclusion in the multiple 
logistic regression model was having been statisti-
cally significant in a preliminary simple logistic regres-
sion, and as a result of this, boys were not included. 
Regression coefficients, Wald statistics and ORs with 
95% CIs were assessed in two different models assess-
ing behavioural risk factors and health(care)-related 
factors for the CT test results. 
Data protection was assured, as no patient-identifying 
data were made available to us. Approval was granted 




We tested urine samples of 1,925 KiGGS participants: 
789 boys aged 16–17 years and 1,136 girls aged 15–17 
years. These numbers represent all study participants 
for whom urine samples were available. Overall, urine 
samples were collected for 92% of boys and 83% of 
girls in the respective age groups. We did not see a 
systematic bias in those who provided a urine sample, 
as there was no difference in their socio-demographic 
variables compared with those who did not provide 
a sample. The 1,925 participants included could be 
regarded as representative of the German population 
based on the geographical area of residence, the size 
of the residential municipality and social status (data 
not shown).
Prevalence of C. trachomatis infection
Overall, the weighted prevalence of CT infection was 
2.2% among the girls tested and 0.2% among the boys 
(Table 1). The prevalence increased by age in the girls, 
being highest (3.3%; 95% CI: 1.8–6.1) in those aged 17 
years. 
Behavioural risk factors/indicators
No difference in geographical region of residence, size 
of residential municipality, migrant status or educa-
tional level could be found between CT-positive and 
CT-negative participants. Girls from low or medium 
social status were five times more likely to be 
CT-positive than girls from high social status (2.8% of 
girls from low or medium social status were CT-positive 
compared with 0.5% of girls from high social status 
(OR: 5.4; 95% CI: 0.9–31.4).
A large majority of participants reported that they 
consumed alcohol, there was no difference between 
CT-positive and CT-negative participants (100% com-
pared with 92.5%). However, in 15 and 16 year-old 
girls, elevated consumption of alcohol (defined as two 
or more glasses per week), and frequent marijuana 
consumption (defined as often or several times) within 
the last 12 months was associated with CT infection, 
as shown in Table 2. Consumption of wine and hard 
Table 1
Urine specimens positive for Chlamydia trachomatis and weighted age- and sex-specific prevalencea of C. trachomatis 










Prevalence of CT infection 
 (95% CI)
15 6/381 1.4 (0.6–3.3) NA NA
16 6/378 1.8 (0.6–4.9) 1/408 0.2 (0.0–1.3)
17 12/377 3.3 (1.8–6.1) 2/381 0.2 (0.1–1.0)
Total 24/1,136 2.2 (1.4–3.5) 3/789 0.2 (0.1–0.7)
CI: confidence interval; CT: Chlamydia trachomatis; KiGGS (German Health Interview and Examination Survey for Children and Adolescents); 
NA: not applicable.
a  Weighted prevalence, as a percentage. As selected persons were representative for the general population, weighted proportions are 
reported. In addition, actual numbers are shown here to allow assessment of the size of the study and number of participants included in 
each subgroup.
b  Samples tested were from 16–17 year-old boys and 15–17 year-old girls.
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liquor was particularly associated with CT infection in 
the 15–16 year-old girls (data not shown).  
Of all the participants tested, 66.6% of those who were 
CT-positive and 38.5% of those who were CT-negative 
smoked tobacco (OR: 3.2; 95% CI: 1.4–7.3). The mean 
number of cigarettes smoked daily was 13.9 in those 
who were CT-positive and 8.7 in those who were 
CT-negative (p=0.02). A total of 89.7% of CT-positive 
and 69.3% of CT-negative participants reported being 
in a smoky room at least once a week (OR: 3.9; 95% CI: 
1.3–11.3). 
Oral contraceptive use was associated with CT infec-
tion. Girls taking them were three times more likely 
to be CT-positive than those who did not (4.1% vs 
1.3%; OR: 3.2; 95%CI: 1.1–8.7). In 15 year-old girls, 
CT-positivity was 5.3% in those who took oral contra-
ceptives and 0.8% in those who did not (OR: 7.3; 95% 
CI: 1.3–42.1). In 16 year-old girls, it was 4.6% in those 
using oral contraceptives and 0.5% in those who did 
not (OR: 9.4; 95% CI: 0.9–96.7). 
A total of 5% of all CT-positive girls were pregnant, 
compared with 0.1% of all who were CT-negative (OR: 
91.1; 95% CI: 5.3–1,560.7). Vice versa, of all pregnant 
girls, 65.8% were CT-positive compared with a preva-
lence of 2.1% in non-pregnant girls. 
A multiple logistic regression analysis was performed 
using CT-positive status as outcome,  three health 
behaviour predictors (frequent marijuana consump-
tion within the last 12 months, being frequently in 
smoky rooms and use of oral contraceptives), as well 
as one social class predictor. As shown in Table 3, 
according to the Wald criterion, only frequent mari-
juana consumption reliably predicted CT-positivity 
(Wald-F(1,164)=7.56; p<0.05). The OR indicates that 
girls frequently smoking marijuana are six times more 
likely to be CT-positive than those who do not frequently 
Table 2
Risk factors for Chlamydia trachomatis infection by C. trachomatis positivity and sex, KiGGS participantsa, Germany, 
2003–2006 (n=1,925)














15 22.0 9.9 2.6 (0.3–24.2) NA NA
16 73.3 16.9 13.5 (2.7–66.7) 100 48.4
17 9.4 21.6 0.4 (0.0–3.0) 0 57.9
Marijuana consumption 
(often/several times)f
15 20.6 1.9 13.1 (1.3–133.2) NA NA
16 43.0 5.3 13.4 (1.2–149.0) 0 9.3
17 16.0 7.4 2.4 (0.5–12.6) 0 12.1
Tobacco smoking
Smokers NA 68.5 35.0 4.0 (1.6–10.0) 43.1 43.0
Mean number of 
cigarettes smoked daily NA 13.3 7.8 p<0.02 22.0 9.6
Mean age when started 
smoking NA 13.6 years 13.9 years p=0.53 11.0 years 14.2 years
Being frequently in smoky roomsg
All participants NA 91.6 66.2 5.6 (1.6–19.4) 65.0 73.4
Smokers only NA 90.0 81.0 2.1 (0.4–10.2) 100 84.1
Non-smokers only NA 94.2 58.4 11.7 (1.4–97.9) 38.6 64.8
CI: confidence interval; CT: Chlamydia trachomatis; KiGGS (German Health Interview and Examination Survey for Children and Adolescents); 
NA: not applicable; OR: odds ratio.
a  Sample comprised 16–17 year-old boys and 15–17 year-old girls.
b  Due to small numbers and lack of statistical significance, no OR is shown for boys. 
c  Applicable for consumption of alcohol and marijuana only. For tobacco smoking, the participants were analysed by the respective age group 
(see footnote a).
d  Weighted percentage, unless otherwise specified (as in Mean number of cigarettes smoked daily and Mean age when started smoking, 
where significance was calculated using Complex Samples General Linear Model for linear regression analysis). As selected persons were 
representative for the general population, (weighted) proportions, not actual numbers, are reported.
e  Consumption of two or more glasses per week in comparison with one glass per week or less. 
f  ‘Often/several times’ in comparison with ‘once/never’.
g  Defined as being in the room daily, several times a week or at least once a week (the duration of stay in the room was not defined).
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smoke marijuana. Although being frequently in smoky 
rooms was not significantly identified as a predictor of 
CT-positivity (F(1,164)=3.53; p=0.06), its effects need 
to be assessed through larger studies. 
Health(care)-related factors
All CT-positive participants were less likely to rate 
their general health status as ‘very good’, compared 
with those who were CT-negative, 2.5% vs 21.0% (OR: 
10.5; 95% CI: 2.3–47.6). CT-positive girls additionally 
reported more frequently repeated episodes of lower 
abdominal pain within the last three months than 
CT-negative girls did, 45.5% vs 23.5% (OR: 2.7; 95% CI: 
1.0–7.3).
Participants with CT more often consulted a doctor 
within the last three months, (82.2% vs 63.2%; OR: 
2.7; 95% CI: 1.1–6.8). In girls, this difference was also 
seen in those visiting a gynaecologist within the last 
12 months, 81.1% in those who were CT-positive com-
pared with 46.0% in those who were CT-negative (OR: 
5.0; 95% CI: 1.4–17.9).
The multiple logistic regression analysis to predict 
CT-positive status in girls showed that only general 
health status ‘very good’ significantly improved the 
model (F(1,164)=3.83, p=0.052). The OR and regres-
sion weight indicated that having a general health 
status that was not considered ‘very good’ increased 
the chance of being CT-positive. The other two predic-
tors of the logistic regression model were repeated 
episodes of lower abdominal pain within the last three 
months and a gynaecologist visit within the last 12 
months. According to the Wald criterion, the ladder var-
iable did not significantly predict a positive CT status. 
(F(1,164)=3.40, p=0.07). However, the OR indicates an 
almost five times higher chance of being CT-positive 
if the girl had been to a gynaecologist within the last 
12 months. Another possible predictor of the model 
that was not significant (F(1,164)=1.92; p=0.17) was 
repeated episodes of lower abdominal pain, but the 
OR showed a more than double increased chance of CT 
infection.
Healthcare structures
Overall, adolescents visited the following medical spe-
cialists at their last consultation: general practitioner 
42.4%, paediatrician 12.6%, dermatovenerologist 
6.6% or gynaecologist 8.5%. The medical specialty at 
the last visit by CT-positivity and sex is shown in Table 
4.
Discussion
In this first, representative, population-based study of 
adolescents in Germany, we found an increase in the 
prevalence of CT infection with age in girls. As partici-
pants were unaware of their test results when filling 
out the questionnaire, we consider that their responses 
were unbiased. The estimated prevalence was particu-
larly high in those who reported oral contraceptive 
use or who were pregnant. Independent predictors 
of CT infection were found to be frequently smoking 
marijuana and a general health status less than ‘very 
good’. Social status, consumption of alcohol or mari-
juana and smoking were associated with CT- infection 
rates. Repeated lower abdominal pain was associated 
Table 3
Multivariate logistic regression models of Chlamydia trachomatis prevalence in 15–17 year-old girls as function of behavioural 
risk factors and health(care)-related factors, KiGGS participants, Germany, 2003–2006 (model 1, n=1,041; model 2, n= 945)a
Factor B Wald-F OR (95% CI)
Model 1: Behavioural risk factors
Social class −1.63 2.88 0.20 (0.03–1.31)
Frequent marijuana consumption 1.88 7.56 6.54 (1.70–25.18)
Frequent exposure to smoky rooms 1.47 3.53 4.36 (0.93–20.53)
Oral contraceptive use 0.71 1.30 2.03 (0.59–6.94)
(Constant) −5.18 64.93 NA
Model 2: Health(care) factors
General health status ‘very good’ −2.07 3.83 0.13 (0.02–1.02)
Repeated episodes of lower abdominal pain within last 3 months 0.78 1.92 2.2 (0.72–6.70)
Gynaecologist visit within last 12 months 1.56 3.40 4.77 (0.90–25.46)
(Constant) −5.23 77.82 NA
B: regression weight; CI: confidence interval; KiGGS (German Health Interview and Examination Survey for Children and Adolescents); NA: not 
applicable; OR: odds ratio.
a The fewer numbers are due to missing data.
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with CT infection in girls and infected girls consulted 
a gynaecologist more often than CT-negative girls did. 
An estimation of sexual experience in German youth 
has been reported through another representative 
national study, a telephone survey performed by the 
Federal Centre for Health Education (BzgA) during the 
same time period [22]. In this study, 2,500 randomly 
chosen adolescents aged 14–17 years were asked 
about their attitudes and behaviour concerning sexual-
ity and contraception. Some 23% of the 15 year-old girls 
were sexually experienced, reaching 73% in 17 year-old 
girls. A total of 35% and 66% of 16 and 17 year-old boys 
respectively were sexually experienced. Taking these 
results into account, our findings showed the highest 
prevalence of CT infection (6.8%) in 15 year-old girls 
who were presumably sexually experienced. Overall, 
the prevalence in girls aged 15–17 years was 4.4% and 
0.8% in 16–17 year-old boys. However, participants in 
both surveys were probably not identical, limiting fur-
ther analysis.
A 2.2% prevalence of CT infection in all girls aged 
15–17 years in our study in Germany was lower than 
the 3.9% found by Forhan et al. in females aged 14–19 
years in the United States [14]. The highest prevalence 
we found, in 15 year-old girls presumed to be sexually 
experienced (6.8%), was comparable to the 7.1% found 
in sexually experienced female NHANES participants 
in the United States [14]. Most other population-based 
studies were performed in sexually experienced par-
ticipants aged 18–24 years, showing among women a 
prevalence of 3.6% (95% CI: 1.9-6.8) in France, 4.7% 
(95% CI: 2.5–8.5) in Slovenia  and 3.0% (95% CI: 1.7–
5.0) in the UK [12,13,23]. In an observational study per-
formed in 2004 among sexually experienced females 
aged 14–20 years in Berlin, Germany, CT-positivity of 
6.5% (95% CI: 4.7–9.0) was found [24]. In a study per-
formed in 2008–09 in a mid-sized town in Germany, 
a prevalence of 4.2% was found in 14–19 year-old 
females and was associated with an early age of first 
sexual contact and increasing number of lifetime sex-
ual partners [25]. The prevalence in our study might 
have been underestimated due to the long storage time 
between taking of specimens being taken and testing. 
In addition, if the collected urine was not first-void, 
there could be a reduction in sensitivity [3,26,27]. 
In our study, prevalence of CT infection was higher in 
girls than in boys. Men in general are reported to have 
CT infections at an older age than women [28, 29]. The 
reason could be that (younger) females tend to have 
sex with older males, as shown in previous studies 
[30, 31]. Bridging by age (defined as having sexual 
partners in more than one age group) was a predictor 
for reduced condom use, probably due to differences 
in power to make decisions on contraceptive use with 
older partners [30,32]. Furthermore, ‘age-bridgers’ 
engaged in more risky sexual behaviour in a cohort of 
CT-positive heterosexual young men aged 14–24 years 
[33]. Other reasons for higher prevalence in young 
girls could be cervical ectopy [34], earlier sexual debut 
or more partners during this earlier period of sexual 
experience [23,25].
Table 4
Medical specialty visited at last consultation by Chlamydia trachomatis-positivity and sex, KiGGS participantsa, Germany, 
2003–2006 (n=1,925)
CI: confidence interval; CT: Chlamydia trachomatis; KiGGS (German Health Interview and Examination Survey for Children and Adolescents); 
NA: not applicable; OR: odds ratio.
a  Sample comprised 16–17 year-old boys and 15–17 year-old girls.
b  Due to small numbers and lack of statistical significance, no OR is shown for boys. 
c  Weighted percentage. As selected persons were representative for the general population, (weighted) proportions, not actual numbers, are 
reported.
d  Comprised internist, orthopaedist, otorhinolaryngologist (ear, nose and throat doctor), neurologist/psychiatrist, psychologist, surgeon, 
radiologist, urologist, school physician, other doctor.













General practitioner 44.3 40.7 1.2 (0.5–2.8) 22.0 49.1
Gynaecologist 24.3 15.0 1.8 (0.7–4.6) 0.0 0.0
Ophthalmologist 15.7 4.5 4.0 (0.8–19.8) 0.0 3.7
Paediatrician 9.9 12.4 0.8 (0.2–2.9) 35.0 12.8
Dermatovenerologist 0.0 6.3 NA 43.1 7.1
Otherd 5.8 21.1 0.2 (0.1–1.0) 0.0 27.2
7www.eurosurveillance.org
Poor healthcare-seeking behaviour associated with 
higher infection rates, lower partner referral or inad-
equate care have been reported for people with lower 
socio-economic status in many countries [35-37]: our 
findings of a higher prevalence in girls with low or 
medium social status are therefore not surprising. In 
Germany, a quarterly fee has to be paid by persons 
insured by one of the general health insurances in 
order to access healthcare, posing a possible barrier 
for people with a small income. Therefore the higher 
prevalence in groups with low or medium social sta-
tus could be due to a lower healthcare use and subse-
quently a lower chance to be tested for CT [38-40]. 
Although the number of participants in our study was 
small, we found an association between alcohol con-
sumption and infection, particularly in younger girls. 
Excessive consumption of alcohol has been reported 
in association with an increase in sexual encounters 
and multiple (new) sexual partners and engagement in 
(unprotected) casual sex [41, 42]. In a study performed 
among female Irish students, consumption of alcohol 
by the person themselves or by their partners was the 
most frequent cause of unprotected sex [43]. Alcohol 
consumption can lead to failure in condom usage, such 
as breakage or falling off, and was positively associ-
ated with infection if male partners had drunk alcohol 
[44,45]. 
We found that tobacco smoking was associated with 
CT infection, similar to the findings of a study among 
women aged 18–25 years in Costa Rica [46]. The immu-
nosuppressive effect of cigarette smoking on the cervi-
cal epithelium – due to a decrease in the concentration 
of Langerhans’ cells and hence reduced ability to pre-
sent viral antigens to T lymphocytes and subsequent 
persistence of local viral infection and the increased 
likelihood of the development of a virally induced neo-
plastic transformation – has been shown for human 
papillomavirus previously [47]. Smoke-induced per-
sistent C. pneumoniae infections have been observed 
in endothelial cells [48]. Whether there is a biological 
effect of smoking on CT infection is, however, unknown 
and warrants further investigation. In our studied pop-
ulation, it is also possible that smoking was associ-
ated with an active nightlife, resulting in smoking and 
drinking with peers and more frequently engaging in 
casual sex; unfortunately, however, there was no sys-
tematic gathering of this information in the survey. 
Adolescents who reported being frequently in smoky 
rooms might also be from families with lower social 
status and hence smoking might be a confounder. 
Nevertheless, a dose–response relationship in the 
number of cigarettes smoked per day supports some 
effect of smoking in our study. 
An association between the consumption of marijuana 
and CT infection was found in African-American ado-
lescents [49]. In a representative survey performed by 
BzgA in 2011, no association between taking illegal 
drugs – dominated by marijuana in Germany – and 
social or educational status was found [50]; hence, 
social class might have little influence on marijuana 
consumption in Germany.
Oral contraceptive use and pregnancy was positively 
associated with CT infection in our study, as previously 
reported [34,45,51]. One explanation could be that 
young girls who take the pill no longer use condoms 
[24], as pregnancy prevention has been frequently 
reported as a major reason for condom use in young 
females. In the United States, an increase in oral con-
traceptive intake from 8% in 9th-grade females to 30% 
in 12th-grade females was found as was a concomitant 
decrease in condom use from 56% to 49% in those sex-
ually active females [52]. We do not know if the preg-
nancies in our study were unwanted;  however, in the 
UK, which has the highest teenage-pregnancy rates in 
Western Europe [53], CT infection rates are very high 
in young girls too, with 3,027 reported infections per 
100,000 population in females aged 15–19 years in 
2011 in England [54]. In our study, the number of preg-
nant girls was very low, and hence the confidence 
intervals were very wide. 
CT-positive girls more frequently reported lower 
abdominal pain than CT-negative girls. These symp-
toms may be related to CT infection as lower abdomi-
nal pain has been described in acute CT infection and 
also in patients with pelvic inflammatory disease [55]. 
In our study however, we do not know whether par-
ticipants were aware of a possible previous untreated 
CT infection or the detailed time frame of pain. Also, 
lower abdominal pain can have many causes and it is 
therefore difficult to establish a causal link between 
lower abdominal pain and CT infection. Even if the pain 
was linked to CT infection, physicians might not have 
considered CT infection and might not have taken their 
sexual history. Our study was performed in 2003–2006 
and CT screening for young sexually active women was 
only introduced in 2008 in Germany. Therefore, physi-
cians were unable to test asymptomatic persons free 
of charge at that time and consequently might have 
missed some CT infections. 
Currently, annual CT screening for sexually active 
women under the age of 25 years can be performed 
using urine samples [56] and it is common practice for 
this to be done at gynaecologists’ practices; however, 
the extent of screening uptake is currently unknown in 
Germany. From our study, we recommend extending the 
screening guidelines to other specialties in Germany, 
such as GPs, paediatricians and dermatovenerologists, 
as in our study, the majority of adolescents attended 
these doctors and as urine can easily be collected in 
these practices.  
There are several limitations of our study. First, no 
data on sexual activity were collected; estimation of 
sexual activity had to be derived from another national 
representative study, thus posing a risk of uncer-
tainty. However, as both surveys were representative, 
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behavioural data from the other representative sur-
vey were applied to our participants. Second, lower 
abdominal pain was reported by participants and 
not verified by clinical examination during the study 
visit. Similarly, information on most other risk factors 
analysed were self-reported and recall-bias or social 
expectancy is possible. However, as participants were 
unaware of their CT-infection status, this bias is likely 
to be equally distributed. Third, as the number of urine 
samples positive for CT was low, this led to wide con-
fidence intervals in the univariate and multivariable 
analysis. Therefore, it is possible that more risk fac-
tors would have been identified if there had been a 
larger sample size or higher prevalence. Nevertheless, 
we believe that the results presented in this paper are 
valuable, as it is very difficult to obtain such a large, 
representative sample size. 
Recommendations
To reduce CT prevalence, particularly in young girls, a 
number of interventions need to take place in Germany. 
•	 Sex education needs to be enhanced before sex-
ual debut and safe sex practices promoted with 
all new partners, regardless of the contraceptive 
method used. 
•	 All sexually active girls and boys should be offered 
a CT test when attending a medical doctor. Those 
tested positive should be treated adequately, 
regardless of whether or not they have symp-
toms, to reduce the prevalence in the community. 
Asymptomatic men represent a reservoir for CT, 
potentially leading to females becoming infected. 
In a study of asymptomatic couples in Germany 
in 1996 using ligase chain reaction, more infec-
tions were detected in urine specimens from males 
than from females [57]: this supports the inclu-
sion of men in CT screening. It has been shown 
that screening coverage needs to increase up to 
26–43% to bring about substantial reductions of 
CT prevalence [58]. 
•	 Social discrimination needs to be reduced by ensur-
ing uniform access to the healthcare system. 
•	 Well-informed consumption of alcohol should be 
promoted and the risky behaviour of people 
intoxicated through consumption of marijuana 
highlighted through targeted adolescent health 
campaigns. 
•	 Doctors should be made more aware of the need to 
test for CT and continuing sexual health education 
for doctors adopted. Screening should be extended 
to other specialties , so that urine samples for test-
ing are taken at all consultations, not just those 
of gynaecologists. A GP’s surgery can be an ideal 
place for CT screening, as adolescents perceive it 
as a normal place to discuss health issues [59] and 
hence can particularly be used to increase testing 
in boys. 
•	 Appropriate models should be created for payment 
of counselling, particularly regarding contracep-
tion and sexual behaviour. 
For the next round of this population-based survey 
starting at the end of 2013, it is encouraged to test 
specimens for CT shortly after sampling to reduce 
possible loss in sensitivity due to long storage. In 
addition, basic questions regarding sexual behaviour 
should be included. Finally, repeated cross-sectional 
surveys on a representative sample of German youth 
will provide information on possible changes in preva-
lence and risk behaviour and hence allow revaluation 
of recommendations.
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